Cargando…

Immunohistochemistry Heterogeneity in Reported Breast Cancer Demographics From India: Triple-Negative Breast Cancer Rates Could Be Lower Than Suggested in Pooled Meta-Analysis

Detalles Bibliográficos
Autores principales:	Chatterjee, Sanjoy, Arun, Indu, Agrawal, Sanjit, Arunsingh, Moses, Mallick, Indranil, Ahmed, Rosina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Clinical Oncology 2016
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493280/ https://www.ncbi.nlm.nih.gov/pubmed/28717757 http://dx.doi.org/10.1200/JGO.2016.006635

Ejemplares similares

Oncologic safety of breast conservation following NACT in women with locally advanced breast cancer
por: Agrawal, Sanjit Kumar, et al.
Publicado: (2023)

Stigma Perceived by Women Following Surgery for Breast Cancer
por: Tripathi, Lopamudra, et al.
Publicado: (2017)

Geographic disparities in access to cancer clinical trials in India
por: Chakraborty, Santam, et al.
Publicado: (2021)

Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators?
por: Chatterjee, Sanjoy, et al.
Publicado: (2015)

Effect of non-sentinel metastasis on adjuvant treatment decisions and survival in Z0011 eligible non-screened detected breast cancer population
por: Agrawal, Sanjit Kumar, et al.
Publicado: (2021)

PDL1 expression and its correlation with outcomes in non-metastatic triple-negative breast cancer (TNBC)
por: Ghosh, Joydeep, et al.
Publicado: (2021)

Real-world results of definitive chemoradiation in carcinoma oesophagus: can SCOPE1 results be replicated outside trial setting?
por: Bhattacharyya, Tapesh, et al.
Publicado: (2021)

An Advanced Deep Learning Approach for Ki-67 Stained Hotspot Detection and Proliferation Rate Scoring for Prognostic Evaluation of Breast Cancer
por: Saha, Monjoy, et al.
Publicado: (2017)

Diagnostic Performance of Indocyanine Green Plus Methylene Blue Versus Radioisotope Plus Methylene Blue Dye Method for Sentinel Lymph Node Biopsy in Node-Negative Early Breast Cancer
por: Agrawal, Sanjit Kumar, et al.
Publicado: (2020)

Evaluating Quality Indicators of Glioblastoma Care: Audit Results From an Indian Tertiary Care Cancer Center
por: Basu Achari, Rimpa, et al.
Publicado: (2022)

Diagnostic performance and survival outcome following sentinel lymph node biopsy in breast cancer patients from a tertiary cancer centre in India
por: Agrawal, Sanjit Kumar, et al.
Publicado: (2022)

Teaching breast cancer surgery in India: challenges and opportunities
por: Agrawal, Sanjit Kumar, et al.
Publicado: (2022)

Is COMBIPECS the answer to perioperative analgesia for breast surgery? A double blinded randomized controlled trial
por: Khemka, Rakhi, et al.
Publicado: (2019)

Breast cancer in togolese women: immunohistochemistry subtypes
por: Adani-Ifè, Ablavi, et al.
Publicado: (2020)

Chest wall perforator flaps in partial breast reconstruction after breast conservation surgery: an additional oncoplastic surgical option
por: Agrawal, Sanjit Kumar, et al.
Publicado: (2020)

Assessment of skin response in T4b breast carcinoma patients post-neoadjuvant chemotherapy
por: Sharma, Abhishek, et al.
Publicado: (2021)

Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers
por: Klimov, Sergey, et al.
Publicado: (2017)

High claudin-4 antigen expression in triple-negative breast cancer by the immunohistochemistry method
por: Naimi, Azar, et al.
Publicado: (2022)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

The pathology of familial breast cancer: Immunohistochemistry and molecular analysis
por: Osin, Pinchas P, et al.
Publicado: (1999)

Assessment of breast cancer immunohistochemistry and tumor characteristics in Nigeria
por: Aliyu, Usman Malami, et al.
Publicado: (2020)

ICON-P – A double-blind evaluation of quality improvements with individualized CONstraints from low-cost knowledge-based radiation therapy planning in prostate cancer
por: Saha, Saheli, et al.
Publicado: (2023)

Adjuvant radiation therapy in breast cancer: Recent advances & Indian data
por: Chakraborty, Santam, et al.
Publicado: (2021)

The value of immunohistochemistry in sentinel lymph node histopathology in breast cancer
por: Klevesath, M B, et al.
Publicado: (2005)

Tissue Expression Of LPHN3 in Breast Cancer: An Immunohistochemistry Method
por: Kotepui, Kwuntida Uthaisar, et al.
Publicado: (2020)

Detection of Axillary Lymph Node Involvement in Early-Stage Breast Cancer: Comparison between Staging (18)F-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography–Computed Tomography Scans, Mammography, and Sentinel Lymph Node Biopsy
por: Gupta, Raju, et al.
Publicado: (2023)

Prioritizing Delivery of Cancer Treatment During a COVID-19 Lockdown: The Experience of a Clinical Oncology Service in India
por: Mallick, Indranil, et al.
Publicado: (2021)

Breast Cancer Diagnosis Using a Microfluidic Multiplexed Immunohistochemistry Platform
por: Kim, Minseok S., et al.
Publicado: (2010)

Basal keratin expression in breast cancer by quantification of mRNA and by immunohistochemistry
por: Kordek, Radzislaw, et al.
Publicado: (2010)

N-Acetylgalactosaminyltransferase-14 as a potential biomarker for breast cancer by immunohistochemistry
por: Wu, Chen, et al.
Publicado: (2010)

Digital immunohistochemistry: new horizons and practical solutions in breast cancer pathology
por: Laurinavicius, Arvydas, et al.
Publicado: (2013)

Concordance of Immunohistochemistry-Based and Gene Expression-Based Subtyping in Breast Cancer
por: Holm, Johanna, et al.
Publicado: (2020)

Application of Immunohistochemistry in Clinical Practices as a Standardized Assay for Breast Cancer
por: Masuda, Shinobu, et al.
Publicado: (2023)

Immunohistochemistry-derived subtypes of breast cancer distribution in four regions of Ethiopia
por: Belachew, Esmael Besufikad, et al.
Publicado: (2023)

RNA Sequencing in Comparison to Immunohistochemistry for Measuring Cancer Biomarkers in Breast Cancer and Lung Cancer Specimens
por: Sorokin, Maxim, et al.
Publicado: (2020)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer
por: Besusparis, Justinas, et al.
Publicado: (2016)

Presentation of the Molecular Subtypes of Breast Cancer Detected By Immunohistochemistry in Surgically Treated Patients
por: Kondov, Borislav, et al.
Publicado: (2018)

Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
por: Agersborg, Sally, et al.
Publicado: (2018)

Assessment of the Spatial Heterogeneity of Breast Cancers: Associations Between Computed Tomography and Immunohistochemistry
por: Woolf, David K, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fgsle4fcjp1hkimgp2lreqv8lf